154 related articles for article (PubMed ID: 28074529)
1. Epigenetic-mediated immune suppression of positive co-stimulatory molecules in chemoresistant ovarian cancer cells.
Cacan E
Cell Biol Int; 2017 Mar; 41(3):328-339. PubMed ID: 28074529
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
Cacan E; Ali MW; Boyd NH; Hooks SB; Greer SF
PLoS One; 2014; 9(1):e87455. PubMed ID: 24475290
[TBL] [Abstract][Full Text] [Related]
3. Histone Deacetylase-1-mediated Suppression of FAS in Chemoresistant Ovarian Cancer Cells.
Cacan E
Anticancer Res; 2016 Jun; 36(6):2819-26. PubMed ID: 27272793
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.
Cacan E
J Chemother; 2017 Jun; 29(3):173-178. PubMed ID: 28102109
[TBL] [Abstract][Full Text] [Related]
5. Effector function of CTLs is increased by irradiated colorectal tumor cells that modulate OX-40L and 4-1BBL and is reversed following dual blockade.
Kumari A; Garnett-Benson C
BMC Res Notes; 2016 Feb; 9():92. PubMed ID: 26872462
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced modulation of immunogenic genes in tumor cells is regulated by both histone deacetylases and DNA methyltransferases.
Cacan E; Greer SF; Garnett-Benson C
Int J Oncol; 2015 Dec; 47(6):2264-75. PubMed ID: 26458736
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.
Ali MW; Cacan E; Liu Y; Pierce JY; Creasman WT; Murph MM; Govindarajan R; Eblen ST; Greer SF; Hooks SB
PLoS One; 2013; 8(3):e60185. PubMed ID: 23533674
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo.
Li Q; Ai J; Song Z; Liu J; Shan B
Cell Mol Immunol; 2008 Oct; 5(5):379-84. PubMed ID: 18954562
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.
Peng D; Kryczek I; Nagarsheth N; Zhao L; Wei S; Wang W; Sun Y; Zhao E; Vatan L; Szeliga W; Kotarski J; Tarkowski R; Dou Y; Cho K; Hensley-Alford S; Munkarah A; Liu R; Zou W
Nature; 2015 Nov; 527(7577):249-53. PubMed ID: 26503055
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.
Ceccarelli V; Ronchetti S; Marchetti MC; Calvitti M; Riccardi C; Grignani F; Vecchini A
Biochim Biophys Acta Gene Regul Mech; 2020 Feb; 1863(2):194481. PubMed ID: 31923609
[TBL] [Abstract][Full Text] [Related]
11. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
13. Expression of co-stimulatory 4-1BB ligand induces significant tumor regression and protective immunity.
Xiang J
Cancer Biother Radiopharm; 1999 Oct; 14(5):353-61. PubMed ID: 10850320
[TBL] [Abstract][Full Text] [Related]
14. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
15. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
[TBL] [Abstract][Full Text] [Related]
16. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
[TBL] [Abstract][Full Text] [Related]
17. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis.
Meier JC; Haendler B; Seidel H; Groth P; Adams R; Ziegelbauer K; Kreft B; Beckmann G; Sommer A; Kopitz C
Cancer Med; 2015 Feb; 4(2):253-67. PubMed ID: 25490861
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB ligand signaling to T cells limits T cell activation.
Eun SY; Lee SW; Xu Y; Croft M
J Immunol; 2015 Jan; 194(1):134-41. PubMed ID: 25404362
[TBL] [Abstract][Full Text] [Related]
20. Nuclear-localized costimulatory molecule 4-1BBL promotes colon cancer cell proliferation and migration by regulating nuclear Gsk3β, and is linked to the poor outcomes associated with colon cancer.
Ge Y; Chen W; Zhang X; Wang H; Cui J; Liu Y; Ju S; Tian X; Ju S
Cell Cycle; 2020 Mar; 19(5):577-591. PubMed ID: 31992123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]